Position in STTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,151,883
+$1,895,173 QoQ
Shares Held
645,705
+4.4% QoQ
Ownership
0.842%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $17,775,077,848 across 529 Biotechnology names. STTK ranks #209 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in STTK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,151,883 | 645,705 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,256,710 | 618,277 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,118,421 | 467,959 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $370,623 | 467,959 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $886,747 | 933,419 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,102,874 | 911,467 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,183,584 | 912,202 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,489,705 | 904,069 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $4,002,777 | 447,738 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,641,073 | 370,417 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $521,264 | 342,937 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,022,711 | 327,792 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,017,783 | 346,185 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $796 | 346,185 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $892,836 | 330,680 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,090,341 | 268,557 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,951,488 | 458,096 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,831,108 | 450,189 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,792,808 | 431,443 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $10,538,212 | 363,512 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,128,419 | 243,790 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $12,631,963 | 241,022 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||